Faron, etusivu

releases and announcements

Proposed Issue and Placing

Regulatory

BEXMAB study update

Regulatory

Faron’s Financial Calendar for 2023

BEXMAB Study Update

Regulatory

Faron Appoints Maija Hollmén PhD as CSO

Regulatory

Amendment Terms and Conditions with IPF Partners

Regulatory

Faron Announces Poster Presentation at SITC

BEXMAB Study Update

Regulatory

Holding(s) in Company

Shareholder announcement Regulatory

Holding(s) in Company

Shareholder announcement Regulatory
PreviousNext
Back to top